Form 8-K - Current report:
SEC Accession No. 0000950157-24-001164
Filing Date
2024-09-04
Accepted
2024-09-04 07:46:56
Documents
15
Period of Report
2024-09-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT form8-k.htm   iXBRL 8-K 33201
2 PRESS RELEASE ex99-1.htm EX-99.1 46703
6 image0.jpg GRAPHIC 15895
  Complete submission text file 0000950157-24-001164.txt   247574

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtrs-20240904.xsd EX-101.SCH 3862
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtrs-20240904_lab.xml EX-101.LAB 21966
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtrs-20240904_pre.xml EX-101.PRE 16042
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 4054
Mailing Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317
Business Address 1000 MYLAN BOULEVARD CANONSBURG PA 15317 (724) 514-1465
Viatris Inc (Filer) CIK: 0001792044 (see all company filings)

EIN.: 834364296 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39695 | Film No.: 241275897
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)